Ronald Kamdem
Stock Analyst at Morgan Stanley
(0.96)
# 1984
Out of 5,329 analysts
202
Total ratings
50.00%
Success rate
-5.36%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CURB Curbline Properties | Maintains: Equal-Weight | 27 26 | 23.2 | 12.07% | 2 | Apr 24, 2025 | |
CBRE CBRE Group | Maintains: Overweight | 165 160 | 123.58 | 29.47% | 4 | Apr 24, 2025 | |
MAC Macerich | Maintains: Equal-Weight | 20 19 | 14.68 | 29.43% | 2 | Apr 1, 2025 | |
LINE Lineage | Maintains: Overweight | 80 75 | 47.31 | 58.53% | 2 | Apr 1, 2025 | |
AHR American Healthcare ... | Maintains: Overweight | 36 37 | 31.8 | 16.35% | 4 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 4 | 4.61 | -13.23% | 6 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 3 3 | 2.17 | 3.69% | 10 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 26 28 | 36.01 | -22.24% | 7 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 53 53 | 47.2 | 12.29% | 4 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 23 22 | 11.97 | 83.79% | 2 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 25 | 23.16 | 7.94% | 1 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 293 315 | 300.12 | 4.96% | 17 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 132 133 | 103.17 | 28.91% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Equal-Weight | 62 | 57.16 | 8.47% | 7 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 103 108 | 150.39 | -28.52% | 5 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 33 33 | 31.5 | 4.76% | 4 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 9 7 | 7.84 | -10.71% | 1 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 2 2 | 0.34 | 370.59% | 15 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 18 21 | 28.69 | -26.8% | 10 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 143 145 | 158.87 | -8.73% | 3 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 14 18 | 18.36 | -1.96% | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 62 75 | 72.47 | 3.49% | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 115 150 | 148.43 | 1.06% | 20 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 32 | 37.22 | -14.02% | 20 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 45 47 | 65.59 | -28.34% | 3 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 40 40 | n/a | n/a | 5 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 30 24 | 14.6 | 60.96% | 7 | Jul 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 38 35 | 53.53 | -34.62% | 5 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 68 67 | 64.34 | 4.13% | 6 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 20 19 | 15.87 | 19.72% | 6 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 25 26 | n/a | n/a | 5 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 45 46 | 41.27 | 11.46% | 6 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 77 73 | 76.91 | -5.08% | 3 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 195 150 | 164.21 | -8.65% | 1 | Oct 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 41 48 | n/a | n/a | 1 | Jun 3, 2021 |